Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of TAUNS Laboratories,Inc.. A complete text table follows the diagram.
Interim sales fall on distributor inventory, but the second quarter rebounds as a new Fuji-Mishima plant begins full operation.
Swipe to explore
Every category amount is a reported EDINET XBRL fact. Nodes described as arithmetic bridges are calculated residuals and do not imply a separately reported filing line.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| COVID single-test kits | 1 | 2.2B | 26.5% of reported total |
| COVID/influenza combo kits | 1 | 3.4B | 40.7% of reported total |
| Influenza test kits | 1 | 1.6B | 19.3% of reported total |
| Other diagnostic products | 1 | 1.1B | 13.5% of reported total |
| Product sales bridge | 2 | 8.3B | Major diagnostic-kit sales disclosed in the filing |
| From | To | Value |
|---|---|---|
| COVID single-test kits | Product sales bridge | 2.2B |
| COVID/influenza combo kits | Product sales bridge | 3.4B |
| Influenza test kits | Product sales bridge | 1.6B |
| Other diagnostic products | Product sales bridge | 1.1B |